{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T14:51:05Z","timestamp":1791816665839,"version":"4.3.4"},"reference-count":26,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T00:00:00Z","timestamp":1558569600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPD"],"published-print":{"date-parts":[[2019,5,23]]},"DOI":"10.3233\/jpd-191576","type":"journal-article","created":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T19:00:35Z","timestamp":1551207635000},"page":"301-313","source":"Crossref","is-referenced-by-count":111,"title":["Extended Treatment with Glial Cell Line-Derived Neurotrophic Factor in Parkinson\u2019s Disease"],"prefix":"10.1177","volume":"9","author":[{"given":"Alan L.","family":"Whone","sequence":"first","affiliation":[{"name":"Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK"},{"name":"Neurological and Musculoskeletal Sciences Division, North Bristol NHS Trust, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela","family":"Boca","sequence":"additional","affiliation":[{"name":"Neurological and Musculoskeletal Sciences Division, North Bristol NHS Trust, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Luz","sequence":"additional","affiliation":[{"name":"Med Genesis Therapeutix Inc., Victoria, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Woolley","sequence":"additional","affiliation":[{"name":"Renishaw plc, New Mills, Wotton-under-Edge, Gloucestershire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Mooney","sequence":"additional","affiliation":[{"name":"Neurological and Musculoskeletal Sciences Division, North Bristol NHS Trust, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonali","family":"Dharia","sequence":"additional","affiliation":[{"name":"Neurological and Musculoskeletal Sciences Division, North Bristol NHS Trust, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Broadfoot","sequence":"additional","affiliation":[{"name":"Neurological and Musculoskeletal Sciences Division, North Bristol NHS Trust, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cronin","sequence":"additional","affiliation":[{"name":"Neurological and Musculoskeletal Sciences Division, North Bristol NHS Trust, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Schroers","sequence":"additional","affiliation":[{"name":"Neurological and Musculoskeletal Sciences Division, North Bristol NHS Trust, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil U.","family":"Barua","sequence":"additional","affiliation":[{"name":"Neurological and Musculoskeletal Sciences Division, North Bristol NHS Trust, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Longpre","sequence":"additional","affiliation":[{"name":"Med Genesis Therapeutix Inc., Victoria, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Lynn","family":"Barclay","sequence":"additional","affiliation":[{"name":"Med Genesis Therapeutix Inc., Victoria, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Boiko","sequence":"additional","affiliation":[{"name":"Med Genesis Therapeutix Inc., Victoria, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg A.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Med Genesis Therapeutix Inc., Victoria, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Christian","family":"Fibiger","sequence":"additional","affiliation":[{"name":"Med Genesis Therapeutix Inc., Victoria, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"Harrison","sequence":"additional","affiliation":[{"name":"Renishaw plc, New Mills, Wotton-under-Edge, Gloucestershire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen","family":"Lewis","sequence":"additional","affiliation":[{"name":"Renishaw plc, New Mills, Wotton-under-Edge, Gloucestershire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Pritchard","sequence":"additional","affiliation":[{"name":"Renishaw plc, New Mills, Wotton-under-Edge, Gloucestershire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Howell","sequence":"additional","affiliation":[{"name":"Renishaw plc, New Mills, Wotton-under-Edge, Gloucestershire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlie","family":"Irving","sequence":"additional","affiliation":[{"name":"Renishaw plc, New Mills, Wotton-under-Edge, Gloucestershire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Johnson","sequence":"additional","affiliation":[{"name":"Renishaw plc, New Mills, Wotton-under-Edge, Gloucestershire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suk","family":"Kinch","sequence":"additional","affiliation":[{"name":"Renishaw plc, New Mills, Wotton-under-Edge, Gloucestershire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Marshall","sequence":"additional","affiliation":[{"name":"The Wales Research and Diagnostic Positron Emission Tomography Imaging Centre (PETIC), Cardiff University, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Lawrence","sequence":"additional","affiliation":[{"name":"School of Psychology, Cardiff University, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Blinder","sequence":"additional","affiliation":[{"name":"Department of Physics and Astronomy, The University of British Columbia, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesna","family":"Sossi","sequence":"additional","affiliation":[{"name":"Department of Physics and Astronomy, The University of British Columbia, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Jon","family":"Stoessl","sequence":"additional","affiliation":[{"name":"Djavad Mowafaghian Centre for Brain Health, Faculty of Medicine, The University of British Columbia, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Skinner","sequence":"additional","affiliation":[{"name":"Renishaw plc, New Mills, Wotton-under-Edge, Gloucestershire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erich","family":"Mohr","sequence":"additional","affiliation":[{"name":"Med Genesis Therapeutix Inc., Victoria, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven S.","family":"Gill","sequence":"additional","affiliation":[{"name":"Neurological and Musculoskeletal Sciences Division, North Bristol NHS Trust, Bristol, UK"},{"name":"Renishaw plc, New Mills, Wotton-under-Edge, Gloucestershire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JPD-191576_ref1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.pharmthera.2013.01.004","article-title":"GDNF, NGF and BDNF as therapeutic options for neurodegeneration","volume":"138","author":"Allen","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.3233\/JPD-191576_ref2","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nm850","article-title":"Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease","volume":"9","author":"Gill","year":"2003","journal-title":"Nat Med"},{"key":"10.3233\/JPD-191576_ref3","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3171\/jns.2005.102.2.0216","article-title":"Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor","volume":"102","author":"Slevin","year":"2005","journal-title":"J Neurosurg"},{"key":"10.3233\/JPD-191576_ref4","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/ana.20737","article-title":"Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease","volume":"59","author":"Lang","year":"2006","journal-title":"Ann Neurol"},{"key":"10.3233\/JPD-191576_ref5","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/brain\/awz023","article-title":"Randomised trial of intermittent intraputamenal glial cell line-derived neurotrophic factor in Parkinson\u2019s disease","volume":"142","author":"Whone","year":"2019","journal-title":"Brain"},{"key":"10.3233\/JPD-191576_ref6","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/archneurol.2009.295","article-title":"The clinically important difference on the unified Parkinson\u2019s disease rating scale","volume":"67","author":"Shulman","year":"2010","journal-title":"Arch Neurol"},{"key":"10.3233\/JPD-191576_ref7","first-page":"467131","article-title":"Minimal clinically important difference in Parkinson\u2019s disease as assessed in pivotal trials of pramipexole extended release","volume":"2014","author":"Hauser","year":"2014","journal-title":"Parkinsons Dis"},{"key":"10.3233\/JPD-191576_ref8","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1056\/NEJMoa0809335","article-title":"A double-blind, delayed-start trial of rasagiline in Parkinson\u2019s disease","volume":"361","author":"Olanow","year":"2009","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.3233\/JPD-191576_ref9","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1016\/S1353-8020(11)70045-1","article-title":"Neurorestoration","volume":"18","author":"Airavaara","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JPD-191576_ref10","doi-asserted-by":"crossref","first-page":"9567","DOI":"10.1523\/JNEUROSCI.0942-10.2010","article-title":"Regeneration of the MPTP-lesioned dopaminergic system after convection-enhanced delivery of AAV2-GDNF","volume":"30","author":"Kells","year":"2010","journal-title":"J Neurosci"},{"key":"10.3233\/JPD-191576_ref11","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S1474-4422(15)00087-3","article-title":"Multiple-source current steering in subthalamic nucleus deep brain stimulation for Parkinson\u2019s disease (the VANTAGE study): A non-randomised, prospective, multicentre, open-label study","volume":"14","author":"Timmermann","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.3233\/JPD-191576_ref12","first-page":"207","article-title":"The placebo response in Parkinson\u2019s disease. Parkinson Study Group","volume":"22","author":"Shetty","year":"1999","journal-title":"Clin Neuropharmacol"},{"key":"10.3233\/JPD-191576_ref13","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0166-2236(02)02181-1","article-title":"The placebo effect in Parkinson\u2019s disease","volume":"25","author":"De la Fuente-Fernandez","year":"2002","journal-title":"Trends Neurosci"},{"key":"10.3233\/JPD-191576_ref14","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/mds.21894","article-title":"Placebo response in Parkinson\u2019s disease: Comparisons among 11 trials covering medical and surgical interventions","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-191576_ref15","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/mds.10024","article-title":"Placebo-associated improvements in motor function: Comparison of subjective and objective sections of the UPDRS in early Parkinson\u2019s disease","volume":"17","author":"Goetz","year":"2002","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-191576_ref16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.parkreldis.2003.10.003","article-title":"Uncovering the hidden placebo effect in deep-brain stimulation for Parkinson\u2019s disease","volume":"10","author":"De la Fuente-Fernandez","year":"2004","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JPD-191576_ref17","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1006\/exnr.1999.7152","article-title":"Sprouting of dopaminergic axons after striatal injury: Confirmation by markers not dependent on dopamine metabolism","volume":"159","author":"Liberatore","year":"1999","journal-title":"Exp Neurol"},{"key":"10.3233\/JPD-191576_ref18","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1523\/JNEUROSCI.19-05-01708.1999","article-title":"Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor","volume":"19","author":"Batchelor","year":"1999","journal-title":"J Neurosci"},{"key":"10.3233\/JPD-191576_ref19","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1046\/j.1460-9568.2000.00239.x","article-title":"Inhibition of brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor expression reduces dopaminergic sprouting in the injured striatum","volume":"12","author":"Batchelor","year":"2000","journal-title":"Eur J Neurosci"},{"key":"10.3233\/JPD-191576_ref20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0168-0102(00)00097-3","article-title":"The effect of intrastriatal single injection of GDNF on the nigrostriatal dopaminergic system in hemiparkinsonian rats: Behavioral and histological studies using two different dosages","volume":"36","author":"Aoi","year":"2000","journal-title":"Neurosci Res"},{"key":"10.3233\/JPD-191576_ref21","doi-asserted-by":"crossref","first-page":"4969523","DOI":"10.1155\/2016\/4969523","article-title":"Dose-dependent differential effect of neurotrophic factors on in vitro and in vivo regeneration of motor and sensory neurons","volume":"2016","author":"Santos","year":"2016","journal-title":"Neural Plast"},{"key":"10.3233\/JPD-191576_ref22","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1177\/01926230701481899a","article-title":"Six-month continuous intraputamenal infusion toxicity study of recombinant methionyl human glial cell line-derived neurotrophic factor (r-metHuGDNF) in rhesus monkeys","volume":"35","author":"Hovland","year":"2007","journal-title":"Toxicol Pathol"},{"key":"10.3233\/JPD-191576_ref23","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1007\/s00204-018-2222-z","article-title":"Intermittent convection-enhanced delivery of GDNF into rhesus monkey putamen: Absence of local or cerebellar toxicity","volume":"92","author":"Luz","year":"2018","journal-title":"Arch Toxicol"},{"key":"10.3233\/JPD-191576_ref24","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/S1474-4422(10)70254-4","article-title":"Gene delivery of AAV2-neurturin for Parkinson\u2019s disease: A double-blind, randomised, controlled trial","volume":"9","author":"Marks","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.3233\/JPD-191576_ref25","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/ana.24436","article-title":"Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial","volume":"78","author":"Olanow","year":"2015","journal-title":"Ann Neurol"},{"key":"10.3233\/JPD-191576_ref26","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.10720","article-title":"A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson\u2019s disease","volume":"54","author":"Olanow","year":"2003","journal-title":"Ann Neurol"}],"container-title":["Journal of Parkinson's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JPD-191576","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:46:44Z","timestamp":1777610804000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JPD-191576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,23]]},"references-count":26,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jpd-191576","relation":{},"ISSN":["1877-7171","1877-718X"],"issn-type":[{"value":"1877-7171","type":"print"},{"value":"1877-718X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,23]]}}}